ABVC BioPharma Inc. (ABVC) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    ABVC BioPharma Inc.

    NASDAQ: ABVC · Real-Time Price · USD
    2.66
    -0.17 (-6.01%)
    At close: Sep 02, 2025, 1:43 PM

    ABVC BioPharma Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 509.59K 152.43K 969.78K 355.8K
    Cost of Revenue
    		 763.00 302.04K 286.42K 5.09K
    Gross Profit
    		 508.83K -150K 683.37K 350.71K
    Operating Income
    		 -4.71M -6.77M -15.11M -11.71M
    Interest Income
    		 87.36K 185.48K 187.82K 43.2K
    Pretax Income
    		 -5.37M -8.03M -15.52M -11.21M
    Net Income
    		 -4.9M -7.79M -16.42M -12.84M
    Selling & General & Admin
    		 5.04M 5.55M 13.1M 11.05M
    Research & Development
    		 179.27K 1.06M 2.69M 1M
    Other Expenses
    		 -272 -211 1K n/a
    Operating Expenses
    		 5.21M 6.62M 15.8M 12.06M
    Interest Expense
    		 825.9K 1.31M 293.97K 227.21K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 5.21M 6.92M 16.08M 12.06M
    Income Tax Expense
    		 -111K 256.01K 797.78K 825.02K
    Shares Outstanding (Basic)
    		 11.67M 4.34M 3.17M 2.5M
    Shares Outstanding (Diluted)
    		 11.67M 4.34M 3.17M 2.5M
    EPS (Basic)
    		 -0.42 -1.8 -5.2 -5.1
    EPS (Diluted)
    		 -0.42 -1.8 -5.2 -5.1
    EBITDA
    		 -4.34M -6.33M -15.2M -10.97M
    EBIT
    		 -4.54M -6.71M -15.22M -10.98M
    Depreciation & Amortization
    		 200.92K 380.39K 23.8K 11.99K

    Add to Watchlist